All Industries

Top Oncology Companies

290 Oncology companies, sorted by total funding raised.

A2 Biotherapeutics

A2 Biotherapeutics advances its Tmod cell engineering platform to create precision CAR T-cell the...

Agoura Hills, United StatesBiotech, Healthcare
Series CTotal funding$208.5MJan 2025
PMV PharmaIPO

Precision oncology company developing first-in-class small molecule therapies that reactivate mut...

Princeton, United States11–50Biotech, Genomics
Series DTotal funding$206.0MAug 2020
MEI PharmaIPO

MEI Pharma is a clinical-stage pharmaceutical company developing novel small-molecule drug candid...

San Diego, United States11–50Biotech, Oncology
Private EquityTotal funding$202.5MJul 2025
Callio Therapeutics

Callio Therapeutics is a clinical-stage biotech developing dual-payload antibody-drug conjugates,...

Seattle, United States1–10Biotech, Oncology
Series ATotal funding$187.0MMar 2025
Black Diamond TherapeuticsIPO

Black Diamond discovers and develops next-wave precision cancer medicines to treat patients with ...

Cambridge, United States51–200Biotech, Genomics
Series CTotal funding$170.0MDec 2019
Numab

Numab designs and develops a new class of powerful therapeutics for the treatment of severe disea...

Biotech, Drug Discovery
Extension RoundTotal funding$165.0MJan 2025
AVEO OncologyAcquired

Commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines th...

Boston, United States51–200Biotech, Oncology
Venture RoundTotal funding$151.0M
Repare TherapeuticsIPO

A precision oncology company developing highly targeted cancer therapies focused on genomic insta...

Montreal, Canada51–200Biotech, Oncology
Series BTotal funding$150.5MSep 2019
Clovis OncologyIPO

Focused on acquiring, developing and commercializing innovative anti-cancer agents in the US, Eur...

Boulder, United States201–500Biotech, Oncology
Series ATotal funding$145.0MMay 2009
Prelude TherapeuticsIPO

Precision oncology company developing innovative medicines targeting areas of high unmet need in ...

Wilmington, United States51–200Biotech, Oncology
Series CTotal funding$145.0MAug 2020
Sidewinder Therapeutics

Pioneering the next generation of large molecule precision therapeutics to deliver new life-savin...

United StatesBiotech, Oncology
Series BTotal funding$137.0M
Elephas Biosciences

Elephas Biosciences' elive™ platform is designed to provide real-time functional response predict...

Madison, United States51–200Biotech, Genomics
Extension RoundTotal funding$136.5MNov 2025
Nkarta TherapeuticsIPO

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural ...

South San Francisco, United States51–200Biotech, Oncology
Series BTotal funding$126.8MSep 2019
AtrecaClosed

Biopharma startup developing cancer treatments based on human immune response.

Redwood City, United States11–50Biotech, Oncology
Series CTotal funding$125.0MSep 2018
TP TherapeuticsAcquired

Precision oncology company developing structure-based cancer therapies.

San Diego, United States51–200Biotech, Oncology
Series DTotal funding$125.0MOct 2018
MediLink Therapeutics

Innovative ADC drug development company focused on next-generation antibody-drug conjugates for c...

Suzhou, China51–200Oncology
Series BTotal funding$120.0MMar 2022
Storm Therapeutics

Storm Therapeutics is a Cambridge biotechnology company pioneering RNA epigenetics, with first-in...

Cambridge, United States11–50Biotech, Healthcare
Series CTotal funding$119.4MMay 2026
Ionova Bio

Clinical-stage biotech developing targeted and immunotherapies for cancer treatment.

Shenzhen, China51–200Biotech, Healthcare
Venture RoundTotal funding$117.0MAug 2021
Atara BiotherapeuticsIPO

Clinical-stage allogeneic T-cell immunotherapy company developing off-the-shelf cell therapies fo...

Thousand Oaks, United States201–500Biotech, Oncology
Series BTotal funding$110.5MJan 2014
Dispatch Biotherapeutics

Clinical-stage immunotherapy company developing the Flare platform to expand curative potential o...

Philadelphia, United StatesBiotech, Oncology
Series ATotal funding$106.0MJul 2025
AffimedIPO

German-domiciled and NASDAQ-traded company developing a variety of immuno-oncology therapeutics.

Heidelberg, Germany51–200Biotech, Oncology
Series ETotal funding$101.0MSep 2014
Stipple Bio

Biotech developing precision cancer therapies.

Cambridge, United States1–10Biotech, Oncology
Series ATotal funding$100.0MApr 2026
VYRIAD INC

Vyriad is a clinical-stage biotechnology company developing the next generation of targeted genet...

Rochester, United States11–50Biotech, Oncology
Series BTotal funding$95.0MDec 2025
Bolt BiotherapeuticsIPO

Clinical-stage biotech that develops novel immunotherapies using foreign patterns to trigger the ...

San Francisco, United StatesBiotech, Oncology
Series CTotal funding$93.5M
Gritstone Bio

Cancer immunotherapy company developing next-generation, personalized cancer therapeutics

United StatesBiotech, Oncology
Series BTotal funding$92.7MSep 2017